A PYMNTS Company

FTC dismisses complaint to block Omnicare’s acquisition of PharMerica

By  |  June 20, 2012

In light of Omnicare’s dropped bid for PharMerica, the Federal Trade Commission has voted 4-0 to dismiss its complaint to block the deal.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    In the complaint, the FTC asserted that the merger would allow Omnicare to raise the price of drugs for Medicare Part D because the number of skilled nursing facilities receiving services from Omnicare would “dramatically increas[e],” thereby also increasing Omnicare’s bargaining power to raise the price of drugs to Part D health plans.

    Source: Bloomberg

     

    Related content: Interview with Jon Leibowitz